ZA200205167B - gamma-IFN liquid-droplet aerosol and method. - Google Patents

gamma-IFN liquid-droplet aerosol and method.

Info

Publication number
ZA200205167B
ZA200205167B ZA200205167A ZA200205167A ZA200205167B ZA 200205167 B ZA200205167 B ZA 200205167B ZA 200205167 A ZA200205167 A ZA 200205167A ZA 200205167 A ZA200205167 A ZA 200205167A ZA 200205167 B ZA200205167 B ZA 200205167B
Authority
ZA
South Africa
Prior art keywords
gamma
ifn
aerosol
solution
aqueous
Prior art date
Application number
ZA200205167A
Other languages
English (en)
Inventor
J Woodruff Emlen
Peter Van Vlasselaer
Original Assignee
Intermune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intermune Inc filed Critical Intermune Inc
Publication of ZA200205167B publication Critical patent/ZA200205167B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0085—Inhalators using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Colloid Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Liquid Crystal Substances (AREA)
ZA200205167A 1999-12-30 2002-06-27 gamma-IFN liquid-droplet aerosol and method. ZA200205167B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17392699P 1999-12-30 1999-12-30

Publications (1)

Publication Number Publication Date
ZA200205167B true ZA200205167B (en) 2003-11-05

Family

ID=22634096

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200205167A ZA200205167B (en) 1999-12-30 2002-06-27 gamma-IFN liquid-droplet aerosol and method.

Country Status (18)

Country Link
US (1) US20010043906A1 (xx)
EP (1) EP1286658B1 (xx)
JP (1) JP2003519169A (xx)
KR (1) KR20020072563A (xx)
CN (1) CN1230197C (xx)
AT (1) ATE319424T1 (xx)
AU (1) AU4525801A (xx)
BR (1) BR0016884A (xx)
CA (1) CA2395803A1 (xx)
CZ (1) CZ20022220A3 (xx)
DE (1) DE60026618T2 (xx)
HK (1) HK1052876B (xx)
MX (1) MXPA02006518A (xx)
NO (1) NO20023135L (xx)
NZ (1) NZ519773A (xx)
PL (1) PL356817A1 (xx)
WO (1) WO2001049260A2 (xx)
ZA (1) ZA200205167B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6883516B2 (en) * 2000-04-27 2005-04-26 Chrysalis Technologies Incorporated Method for generating an aerosol with a predetermined and/or substantially monodispersed particle size distribution
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
US6964761B1 (en) * 2001-12-12 2005-11-15 New York University Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-γ
DE10218328A1 (de) * 2002-03-05 2003-09-25 Humboldt Uni Zu Berlin Medizin Mittel zur präventiven Therapie nach akutem Schlaganfall
US20050232899A1 (en) * 2002-05-31 2005-10-20 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
US6830744B2 (en) * 2002-05-31 2004-12-14 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
WO2004000266A1 (en) * 2002-06-20 2003-12-31 Yuriy Vasilievich Tyagotin Method for oral transmucosal delivery of interferon
US20040235308A1 (en) 2003-05-22 2004-11-25 Dainippon Screen Mfg. Co., Ltd. Substrate treatment method and sustrate treatment apparatus
AU2005247369A1 (en) * 2004-05-10 2005-12-08 Mdrna, Inc. Compositions and methods for enhanced mucosal delivery of parathyroid hormone
US20070065367A1 (en) * 2005-09-20 2007-03-22 Rany Condos Method of treating pulmonary disease with interferons
CN103550757A (zh) * 2005-09-20 2014-02-05 纽约大学 用干扰素治疗肺病的方法
US8105572B2 (en) * 2007-05-18 2012-01-31 New York University Method of treating tuberculosis with interferons
BRPI0520564A2 (pt) * 2005-09-20 2009-05-19 Univ New York método de tratar doença pulmonar com interferons apoio governamental
US8105571B2 (en) 2005-09-20 2012-01-31 New York University Method of treating pulmonary disease with interferons
WO2008143892A1 (en) * 2007-05-18 2008-11-27 New York University Method of treating tuberculosis with interferons
US8557485B2 (en) * 2008-12-11 2013-10-15 GM Global Technology Operations LLC Tungsten-containing hydrogen-storage materials for anodes of PEM fuel cells
JP2012193207A (ja) * 2012-07-13 2012-10-11 New York Univ インターフェロンを用いる肺疾患の処置方法
WO2016169571A1 (en) * 2015-04-20 2016-10-27 Ghaleb Haider Abbas Pharmaceutical product for treatment & prophylaxis of viral/ microbial infection
CN113491807B (zh) * 2020-04-03 2023-07-28 深圳麦克韦尔科技有限公司 一种气溶胶产生装置
CN116251174B (zh) * 2022-12-23 2023-09-29 北京三元基因药业股份有限公司 一种包含人干扰素α1b吸入溶液的药物组件

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE76311T1 (de) * 1986-08-19 1992-06-15 Genentech Inc Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und zytokinen.
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US5780012A (en) * 1990-06-21 1998-07-14 Huland; Edith Method for reducing lung afflictions by inhalation of cytokine solutions
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US5763401A (en) * 1996-07-12 1998-06-09 Bayer Corporation Stabilized albumin-free recombinant factor VIII preparation having a low sugar content
US5855564A (en) * 1997-08-20 1999-01-05 Aradigm Corporation Aerosol extrusion mechanism

Also Published As

Publication number Publication date
NO20023135L (no) 2002-08-23
KR20020072563A (ko) 2002-09-16
EP1286658A2 (en) 2003-03-05
ATE319424T1 (de) 2006-03-15
DE60026618T2 (de) 2007-01-18
BR0016884A (pt) 2002-10-01
HK1052876A1 (en) 2003-10-03
CZ20022220A3 (cs) 2003-01-15
AU4525801A (en) 2001-07-16
WO2001049260A3 (en) 2002-02-07
EP1286658B1 (en) 2006-03-08
JP2003519169A (ja) 2003-06-17
US20010043906A1 (en) 2001-11-22
CA2395803A1 (en) 2001-07-12
WO2001049260A2 (en) 2001-07-12
MXPA02006518A (es) 2004-07-30
CN1230197C (zh) 2005-12-07
NO20023135D0 (no) 2002-06-27
HK1052876B (zh) 2006-06-16
DE60026618D1 (de) 2006-05-04
NZ519773A (en) 2005-02-25
PL356817A1 (en) 2004-07-12
CN1434701A (zh) 2003-08-06

Similar Documents

Publication Publication Date Title
HK1052876A1 (en) Gamma-ifn liquid-droplet aerosol and method
GEP20043259B (en) Device for Delivery of Aerosolized Active Agent to the Lung of a Human Patient
IL112269A (en) Adhesive compositions for use in transdermal drug delivery systems and method of their preparation
BG104720A (en) Aerosolized active agent delivery
IL112516A0 (en) Thyroid hormone liquid pharmaceutical composition
EP1138275A3 (en) Multiple solution dental irrigator
GEP20043258B (en) Systems and Methods for Aerosolizing Pharmaceutical Formulations
EP2255806A3 (en) Fentanyl composition for nasal administration
UA66812C2 (uk) Препаративна форма лікарського засобу із регульованим вивільненням активної речовини
WO2002024261A3 (en) Shock wave aerosolization apparatus and method
ZA200005033B (en) Improved compositions for inhalation.
NZ513981A (en) Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds
DE69527713D1 (de) Verbindunngen und zusammensetzungen zur verabreichung via inhalation und insufflierung
MX9705185A (es) Particula de resina, material medico y preparacion farmaceutica que contiene dicha particula de resina.
HUP0002478A2 (hu) Perforált mikrorészecskék és felhasználásuk módszerei